Clinical pharmacy services and solid organ transplantation: a literature review
- 820 Downloads
Aim of the review Organ transplantation represents the therapy of choice for most types of end-stage organ failure, and post-transplant patient care warrants great attention. The aim of this study was to summarise the available evidence regarding the role and impact of clinical pharmacy services in the care of solid organ transplant patients. Methods A search of the literature was conducted using the MEDLINE, EMBASE and IPA databases to identify studies relevant to our investigation of the impact of clinical pharmacists’ interventions. Results Only five out of nineteen of the included studies were randomised controlled trials; eleven studies were descriptive, and three were before-after studies. Interventions performed in these studies consisted of routine clinical pharmacy services with a focus on identifying, resolving and preventing drug-related problems; clinical pharmacy services with a focus on therapeutic drug monitoring; and those with a focus on compliance enhancement and educational interventions. The number and type of interventions and the physicians’ acceptance rates were assessed in the majority of the included studies. Acceptance rates were generally above 95%, and most studies reported that clinical pharmacy services had a positive impact on the care of solid organ transplant patients. Positive perceptions of patients and health care professionals are also reported. In two of the studies, patients’ compliance rates and drug knowledge were assessed following counselling by a pharmacist. Dosing-related interventions were the most common interventions proposed. Immunosuppressants, cardiovascular drugs and antimicrobials were the drug classes most affected by the clinical pharmacists’ interventions. Conclusions High quality evidence that supports the benefit of clinical pharmacy services in the care of solid organ transplant patients is rare. Nevertheless, all of the included studies showed that clinical pharmacy services had a positive impact. Furthermore, all included studies showed that patients and physicians appreciated clinical pharmacists. The various outcome measures used in these studies were improved by interactions with clinical pharmacists. More randomised controlled trials are needed to contribute to the paucity of the existing evidence.
KeywordsClinical pharmacy services Immunosuppressant medications Literature review Solid organ transplantation
The authors wish to thank the staff of the pharmacy department of the General Hospital of Vienna for their continual support during the review and the manuscript preparation process.
This literature review was carried out as part of a clinical pharmacy project that was funded by Amgen.
Conflicts of interest
- 3.Lee MA. Transplantation: drug aspects of immunosuppression. Hosp Pharmacist. 2003;10:201–7.Google Scholar
- 9.Burge KL, Simonson DH. Documentation of clinical interventions on a solid organ transplant service. Poster presented at: ASHP Midyear Clinical Meeting. 1992;27(Dec):P-328D.Google Scholar
- 10.Chisholm MA, Bagby TR, DiPiro JT, May JR. Provision of pharmaceutical care services in a renal transplant clinic. Poster presented at: ASHP Midyear Clinical Meeting. 1998;33(Dec):FGF-3.Google Scholar
- 11.Chisholm MA, Reinhardt BO, Vollenweider LJ, Martin BC, DiPiro JT, et al. Effect of pharmaceutical care services on renal transplant patients’ blood glucose levels. Poster presented at: ASHP Midyear Clinical Meeting. 1999;34(Dec):P-148E.Google Scholar
- 12.Chisholm MA, Vollenweider LJ, Reinhardt BO, Rogers HE, DiPiro JT, May JR. Provision of pharmaceutical care services in a renal transplant clinic. Poster presented at: ASHP Midyear Clinical Meeting. 1999;34(Dec):P-149E.Google Scholar
- 13.Chisholm MA, Vollenweider LJ, DiPiro JT. Provision of pharmaceutical care services in a renal transplant clinic. Poster presented at: ASHP Midyear Clinical Meeting. 2000;35(Dec):P-168E.Google Scholar
- 16.Marek TM, Wiland AM, Weidle PJ. Introduction of a clinical pharmacist into a transplant clinic. Poster presented at: ASHP Midyear Clinical Meeting. 1994;29(Dec):P-254(D).Google Scholar
- 17.Mathis AS, Lew L, Adamson RT. Renal transplant faculty documentation of clinical activities using a web-based program and handheld device. ASHP Midyear Clinical Meeting. 2003;38(Dec):P-288(D).Google Scholar
- 18.Oji VU, Okpara AU, Egbunike IG. Implementation of pharmaceutical care with a renal transplant service. Poster presented at: ASHP Midyear Clinical Meeting. 1994;29(Dec):P-367(D).Google Scholar
- 19.Prowse A, Scott D. An evaluation of a clinic-based pharmacist and a medicines home delivery service from a transplant outpatient department. Pharm J. 2004;272:547–51.Google Scholar
- 20.Ptachcinski RJ. Impact of clinical pharmacy services in a liver transplant clinic. Poster presented at: ASHP Midyear Clinical Meeting. 1991;26(Dec):P-263D.Google Scholar
- 23.Mishima K, Makino K, Shimada M, Suehiro T, Oishi R, et al. Roles of pharmacists as a member of the liver transplant team in controlling tacrolimus whole blood concentrations and monitoring adverse drug events such as convulsion. Jpn J Pharm Health Care Sci. 2002;28(4):393–400.Google Scholar
- 25.Klein A, Kramer I. Influence of a pharmaceutical care program on liver transplant patients’ compliance with immunosuppressive therapy: a prospective, randomized, controlled trial. Krankenhauspharmazie. 2007;28(12):458–68.Google Scholar
- 33.Ohler L, Lo A. Transplant pharmacists: key to a successful transplant program. Prog Transpl. 2004;14(2):80–1.Google Scholar
- 36.Wells H. Promoting adherence in renal transplant patients. Hosp Pharmacist. 2004;11:69–71.Google Scholar
- 37.Eurotransplant International Foundation. Annual data reports. Available online at: http://www.eurotransplant.nl/?id=annual_report. Accessed 16 Feb 2009.
- 38.Organ Procurment and Transplantation Network. Data reports. Available online at: http://www.optn.org/data/. Accessed 16 Feb 2009.